Rik Ossenkoppele

Head-to-Head Comparison of Tau and Amyloid Positron Emission Tomography Visual Reads for Differential Diagnosis of Neurodegenerative Disorders: An International, Multicenter Study.

M. Gorno-Tempini, A. Boxer, S. Janelidze, 2024, Annals of neurology.

Rationale and design of the BeyeOMARKER study: prospective evaluation of blood- and eye-based biomarkers for early detection of Alzheimer’s disease pathology in the eye clinic

W. M. van der Flier, Y. Pijnenburg, F. Bouwman, 2024, Alzheimer's research & therapy.

Harmonizing tau positron emission tomography in Alzheimer's disease: The CenTauR scale and the joint propagation model.

Philip S. Insel, W. Jagust, S. Haeberlein, 2024, Alzheimer's & dementia : the journal of the Alzheimer's Association.

Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care.

K. Blennow, S. Janelidze, S. Palmqvist, 2024, JAMA.

Disease progression modelling reveals heterogeneity in trajectories of Lewy-type α-synuclein pathology

C. Belden, S. Mehta, G. Serrano, 2024, Nature communications.